Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2-overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

S. Glück

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)86-87
Number of pages2
JournalBreast Diseases
Volume19
Issue number1
DOIs
StatePublished - Apr 2008

Fingerprint

docetaxel
Neoadjuvant Therapy
Carboplatin
Breast Neoplasms
Trastuzumab
human ERBB2 protein

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

@article{9683b62e90f440eebfaaa8d5fd6d1fcc,
title = "Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2-overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial",
author = "S. Gl{\"u}ck",
year = "2008",
month = "4",
doi = "10.1016/S1043-321X(08)80060-4",
language = "English (US)",
volume = "19",
pages = "86--87",
journal = "Breast Diseases",
issn = "1043-321X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2-overexpressing Stage II or III Breast Cancer

T2 - Results of the GETN(A)-1 Trial

AU - Glück, S.

PY - 2008/4

Y1 - 2008/4

UR - http://www.scopus.com/inward/record.url?scp=41549087400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41549087400&partnerID=8YFLogxK

U2 - 10.1016/S1043-321X(08)80060-4

DO - 10.1016/S1043-321X(08)80060-4

M3 - Article

AN - SCOPUS:41549087400

VL - 19

SP - 86

EP - 87

JO - Breast Diseases

JF - Breast Diseases

SN - 1043-321X

IS - 1

ER -